Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CTC Bio

CTC Bio
1995 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
060590 STOCK SYMBOL
$4.70 SHARE PRICE (As of Friday Closing)
Description

CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

Website
Formerly Known As
World Livestock
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Agricultural Chemicals
Drug Delivery
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • 94 Saengmyeonggwahakgwan-gil
  • Hongcheon-eup, Hongcheon-gun
  • Gangwon-do
  • South Korea

+82 000-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CTC Bio’s full profile, request a free trial.

CTC Bio Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.69 - $10.54 $89.6M $4.53 -$0.72 806K 19M

CTC Bio Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 162,014 187,765 269,951 212,609
Revenue 116,615 125,920 115,134 105,696
EBITDA (1,152) 1,550 (13,805) 2,273
Net Income (13,584) (8,244) (18,253) (2,351)
Total Assets 150,371 171,409 179,486 156,129
Total Debt 61,438 62,747 69,437 62,923
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CTC Bio Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore CTC Bio‘s full profile, request access.

Request full access to PitchBook

CTC Bio Executive Team (5)

Name Title Board
Seat
Contact
Info
Ho Cho Co-Chief Executive Officer, Co-President & Director
Seong Seop Woo Co-Chief Executive Officer & Vice President & Director
Jeon Hong Yeol Managing Director
Jeong Lee Managing Director

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »